NDC 64764-254 – Oseni
Alogliptin Benzoate 25 mg/1; Pioglitazone Hydrochloride 45 mg/1 · Tablet, Film Coated · Oral
Product NDC64764-254
Product details
- Brand name
- Oseni
- Generic name
- Alogliptin and pioglitazone
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- NDA · NDA022426
- Marketed since
- January 25, 2013
- Listing expires
- December 31, 2026
- Pharmacologic class
- Dipeptidyl Peptidase 4 Inhibitor; Peroxisome Proliferator Receptor alpha Agonist; Peroxisome Proliferator Receptor gamma Agonist; Thiazolidinedione
Active ingredients
- Alogliptin Benzoate 25 mg/1
- Pioglitazone Hydrochloride 45 mg/1
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 64764-254-03 | 30 TABLET, FILM COATED in 1 BOTTLE (64764-254-03) | Jan 25, 2013 |
| 64764-254-04 | 90 TABLET, FILM COATED in 1 BOTTLE (64764-254-04) | Jan 25, 2013 |
| 64764-254-05 | 500 TABLET, FILM COATED in 1 BOTTLE (64764-254-05) | Jan 25, 2013 |
Other Oseni products
- 64764-123 Alogliptin Benzoate 12.5 mg/1; Pioglitazone Hydrochloride 30 mg/1 · Tablet, Film Coated · Takeda Pharmaceuticals America, Inc.
- 64764-251 Alogliptin Benzoate 25 mg/1; Pioglitazone Hydrochloride 15 mg/1 · Tablet, Film Coated · Takeda Pharmaceuticals America, Inc.
- 64764-253 Alogliptin Benzoate 25 mg/1; Pioglitazone Hydrochloride 30 mg/1 · Tablet, Film Coated · Takeda Pharmaceuticals America, Inc.